Company intelligence / Profile preview

Twister Biotech

Houston, Texas, USA

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Twister Biotech is a biotechnology company specializing in the development and manufacturing of high-purity, antibiotic-free DNA vectors for gene and cell therapies. The company's proprietary platform produces "Twister DNA," a form of supercoiled minicircle DNA that offers enhanced safety and expression profiles compared to traditional plasmid DNA. By eliminating bacterial backbone sequences and antibiotic resistance genes, Twister Biotech aims to improve the efficacy and regulatory profile of non-viral genetic medicines. Their technology is designed to support a wide range of applications, including DNA vaccines, CAR-T cell engineering, and in vivo gene editing.

Therapeutic areas: OncologyRare DiseasesInfectious Diseases
Modalities: DNA vaccineGene therapyCell therapyNon-viral gene therapy
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Twister Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Twister Biotech.

Explore the full profile